Breaking Down BioNTech: 16 Analysts Share Their Views
Breaking Down BioNTech: 16 Analysts Share Their Views
解讀biontech：16位分析師分享他們的觀點
In examining recent analyst actions, we gain...16 analysts have expressed a variety of opinions on BioNTech (NASDAQ:BNTX) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的一個季度裏，有16位分析師就BioNTech（納斯達克：BNTX）發表了各種不同的觀點，從看好到看淡，意見不一。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了他們最近的評級，揭示了過去30天內情緒的變化，並將其與前幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $126.94, with a high estimate of $150.00 and a low estimate of $91.00. This current average reflects an increase of 18.15% from the previous average price target of $107.44.
分析師對12個月價格目標的評估提供了額外見解，展示了平均目標爲$126.94，最高估價爲$150.00，最低估價爲$91.00。當前的平均值反映了相對於上一個$107.44的平均價格目標的增長幅度爲18.15%。
Decoding Analyst Ratings: A Detailed Look
Decoding Analyst Ratings: A Detailed Look
In examining recent analyst actions, we gain...
通過審查最近的...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間